ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Santen Pharmaceutical Co., Ltd. ?
1
Poor Management Efficiency with a low ROE of 6.50%
- The company has been able to generate a Return on Equity (avg) of 6.50% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Operating profit has grown by an annual rate 4.56% of over the last 5 years
3
Flat results in Dec 25
- OPERATING CASH FLOW(Y) Lowest at JPY 41,411 MM
- INTEREST(9M) At JPY 1,482 MM has Grown at 12.61%
- INVENTORY TURNOVER RATIO(HY) Lowest at 2.42 times
4
Underperformed the market in the last 1 year
- The stock has generated a return of 19.04% in the last 1 year, much lower than market (Japan Nikkei 225) returns of 36.73%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
No Data Found
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
4.43%
EBIT Growth (5y)
4.56%
EBIT to Interest (avg)
20.92
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.32
Sales to Capital Employed (avg)
0.91
Tax Ratio
24.14%
Dividend Payout Ratio
34.62%
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
16.84%
ROE (avg)
6.50%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
1.95
EV to EBIT
9.29
EV to EBITDA
6.84
EV to Capital Employed
2.41
EV to Sales
1.55
PEG Ratio
0.38
Dividend Yield
0.03%
ROCE (Latest)
25.95%
ROE (Latest)
12.52%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
ROCE(HY)
Highest at 10.78%
RAW MATERIAL COST(Y)
Fallen by -0.72% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 4.16 times
-11What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at JPY 41,411 MM
INTEREST(9M)
At JPY 1,482 MM has Grown at 12.61%
INVENTORY TURNOVER RATIO(HY)
Lowest at 2.42 times
DEBT-EQUITY RATIO
(HY)
Highest at -8.96 %
Here's what is working for Santen Pharmaceutical Co., Ltd.
Debtors Turnover Ratio
Highest at 4.16 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -0.72% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Santen Pharmaceutical Co., Ltd.
Interest
At JPY 1,482 MM has Grown at 12.61%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
Operating Cash Flow
Lowest at JPY 41,411 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (JPY MM)
Inventory Turnover Ratio
Lowest at 2.42 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debt-Equity Ratio
Highest at -8.96 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
